U.S. markets open in 7 hours 9 minutes

Evolent Health, Inc. (EVH)

NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
19.75-0.23 (-1.15%)
At close: 4:00PM EDT
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.Learn more
Currency in USD

Valuation Measures

Yahoo Finance Plus required to access annual data
Annual
Quarterly
Yahoo Finance Plus required to access monthly data
Monthly
Subscribe to Yahoo Finance Plus Essential to download historical data
 
As of Date: 5/16/2021
Current
3/31/202112/31/20209/30/20206/30/20203/31/2020
Market Cap (intraday) 5
1.74B1.72B1.35B1.05B608.45M463.99M
Enterprise Value 3
1.80B1.74B1.33B1.32B902.52M729.97M
Trailing P/E
N/AN/AN/AN/AN/AN/A
Forward P/E 1
1.00kN/AN/AN/AN/AN/A
PEG Ratio (5 yr expected) 1
N/AN/AN/AN/AN/AN/A
Price/Sales (ttm)
1.671.681.351.110.670.53
Price/Book (mrq)
2.812.782.151.620.720.50
Enterprise Value/Revenue 3
1.778.084.914.993.782.95
Enterprise Value/EBITDA 7
-9.93156.44148.60-84.88-4.87-13.02

Trading Information

Stock Price History

Beta (5Y Monthly) 2.38
52-Week Change 3144.55%
S&P500 52-Week Change 342.80%
52 Week High 322.35
52 Week Low 35.22
50-Day Moving Average 320.23
200-Day Moving Average 317.77

Share Statistics

Avg Vol (3 month) 3582.8k
Avg Vol (10 day) 3577.26k
Shares Outstanding 586.93M
Implied Shares Outstanding 6N/A
Float 69.18M
% Held by Insiders 18.47%
% Held by Institutions 197.52%
Shares Short (Apr 29, 2021) 48.57M
Short Ratio (Apr 29, 2021) 417.32
Short % of Float (Apr 29, 2021) 49.97%
Short % of Shares Outstanding (Apr 29, 2021) 49.87%
Shares Short (prior month Mar 30, 2021) 48.45M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2020
Most Recent Quarter (mrq)Mar 30, 2021

Profitability

Profit Margin -26.10%
Operating Margin (ttm)-2.73%

Management Effectiveness

Return on Assets (ttm)-1.26%
Return on Equity (ttm)-36.46%

Income Statement

Revenue (ttm)1.02B
Revenue Per Share (ttm)11.97
Quarterly Revenue Growth (yoy)-2.80%
Gross Profit (ttm)233.11M
EBITDA 7.58M
Net Income Avi to Common (ttm)-266.95M
Diluted EPS (ttm)-3.12
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)236.03M
Total Cash Per Share (mrq)2.76
Total Debt (mrq)296.57M
Total Debt/Equity (mrq)48.04
Current Ratio (mrq)1.23
Book Value Per Share (mrq)7.24

Cash Flow Statement

Operating Cash Flow (ttm)-43.85M
Levered Free Cash Flow (ttm)112.3M